Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis (Q68053164)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1531663%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

meta-analysis

0 references

title

Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1531663%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference

1 reference

1 reference

S Roux

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1531663%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

S Christeller

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1531663%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

E Lüdin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1531663%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

language of work or name

English

0 references

publication date

1 March 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1531663%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

21 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1531663%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1531663%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1531663%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

page(s)

671-677

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1531663%20AND%20SRC:MED&resulttype=core&format=json

Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

21 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Meta-analyses of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Maximum likelihood estimation for the beta-binomial distribution and an application to the household distribution of the total number of cases of a disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Randomized comparison of intravenous versus intracoronary streptokinase for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Influence of baseline ejection fraction and success of thrombolysis on mortality and ventricular function after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Non surgical coronary artery recanalization in acute transmural myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Thrombolysis in myocardial infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Recurrent early ischemic events after thrombolysis for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: acute and follow-up studies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Low dose aspirin after early thrombolysis in anterior wall acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

A Randomized Trial of Intracoronary Streptokinase in the Treatment of Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Intracoronary thrombolytic therapy in acute myocardial infarction: a prospective, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980290-6

7 January 2021

10.1016/S0735-1097(10)80290-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1531663%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference